文献速递其他结缔组织病

干燥综合征代谢组揭示生物标志物特征以刻画患者并评估疾病活动性

Sjögren's disease metabolome reveals biomarker signatures to characterise patients and assess disease activity.
PubMed 文献 · RMD Open · 2026-01-05

该研究采用质谱平台检测波兰和英国两个独立队列干燥综合征(SjD)患者的唾液、泪液和血浆代谢组,发现氨基酸代谢与转运通路一致紊乱,并开发出可区分轻度和重度疾病活动的血浆代谢组生物标志物特征。该特征通过简单采血即可用于临床研究,为监测治疗干预提供基础。

要点

  • SjD患者在血浆、唾液和泪液三种基质中均呈现代谢组异质性,氨基酸代谢与转运通路一致紊乱。
  • 基于两队列开发的血浆代谢组生物标志物特征可刻画轻度和重度疾病活动。
  • 该特征通过简单采血即可实施,为未来监测治疗干预提供基础。

核心结论

  • 开发了一种可通过简单采血实施的血浆代谢组生物标志物特征,能刻画SjD患者基线疾病活动性,并为未来研究其监测治疗干预的潜力提供基础。

研究设计与样本

  • 研究采用质谱筛选平台(含4500种参考代谢物)检测波兰队列(30名健康对照和32例SjD患者)和英国队列(13名健康对照和12例SjD患者的纵向样本)的唾液、泪液和血浆代谢组。

主要发现

  • 患者异质性体现在血浆、唾液和泪液三种基质的代谢组中,氨基酸代谢与转运通路存在一致紊乱。
  • 利用两个队列开发的血浆代谢组生物标志物特征可区分疾病活动性较轻和较重的患者。
  • 该特征的相关性得到与γ-谷氨酰循环、嘧啶代谢和性类固醇激素等通路相关代谢物的支持,这些通路此前已被报道在SjD和其他自身免疫病患者中失调。

临床怎么用

  • 该血浆代谢组生物标志物特征可通过简单采血在临床研究中实施,用于刻画SjD患者基线疾病活动性。
  • 该特征为未来研究其监测治疗干预的潜在效用提供了基础。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sjögren's disease (SjD) is a chronic systemic autoimmune disease with heterogeneous glandular and extraglandular manifestations. Although aetiology and pathogenesis of SjD remains elusive, emergence of autoreactive T and B lymphocytes is crucial in disease development. In this study, the metabolome of patients with SjD was characterised to improve disease understanding and to identify biomarkers as tools to aid drug development. METHOD: The metabolome was investigated in saliva, tears and plasma samples from two independent cohorts from Poland (PL) and the UK using a mass spectrometry screening platform with 4500 reference metabolites. The PL cohort included 30 healthy subjects and 32 patients with SjD. The UK cohort encompassed longitudinal samples from 13 healthy subjects and 12 patients with SjD. RESULTS: Patient heterogeneity was reflected in the metabolome across all three matrices (plasma, saliva and tears) with consistent disturbances in the amino acid metabolism and transport pathway. A biomarker signature was developed using both cohorts, which allowed to characterise patients with milder and more severe disease activity. The relevance of the biomarker signature was supported by the presence of metabolites linked to pathways such as gamma-glutamyl cycle, pyrimidine metabolism and sex steroid hormones, which have previously been described to be deregulated in patients with SjD and other autoimmune diseases. CONCLUSION: A plasma metabolome biomarker signature was developed that can be implemented in clinical studies by simple blood collection. The biomarker signature allows to characterise disease activity of patients with SjD at baseline and provides a basis for future studies to investigate its potential utility in monitoring therapeutic intervention.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Suffiotti M, Tanner L, Kozera L, et al. Sjögren's disease metabolome reveals biomarker signatures to characterise patients and assess disease activity. RMD Open. 2026. PMID: 41494737. doi:10.1136/rmdopen-2025-006312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。